CAS 159776-70-2: Melagatran
Formula:C22H31N5O4
InChI:InChI=1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1
InChI key:InChIKey=DKWNMCUOEDMMIN-PKOBYXMFSA-N
SMILES:C([C@H](NCC(O)=O)C1CCCCC1)(=O)N2[C@H](C(NCC3=CC=C(C(=N)N)C=C3)=O)CC2
Synonyms:- Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]-
- Glycine, N-[2-[2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]-, [S-(R*,S*)]-
- H-319/68
- N-[(1R)-2-[(2S)-2-[[[[4-(Aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]glycine
- N-[(1R)-2-{(2S)-2-[(4-carbamimidoylbenzyl)carbamoyl]azetidin-1-yl}-1-cyclohexyl-2-oxoethyl]glycine
- Melagatran
Sort by
Found 8 products.
Melagatran
CAS:Melagatran is a coumarin derivative that acts as a thrombin receptor antagonist. It has been shown to have anti-thrombotic effects in an experimental model of balloon injury and in a vivo model of arterial thrombosis. Melagatran has been shown to significantly inhibit the progression of atherosclerotic lesions when administered orally, without adverse effects on blood coagulation or liver function. This drug may be useful for the prevention or treatment of cardiovascular disease in patients with hepatic impairment. Melagatran is rapidly converted into melagatran in vivo and has no significant pharmacological activity. The drug can be detected by analytical methods such as high performance liquid chromatography (HPLC).Formula:C22H31N5O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:429.51 g/molRef: 3D-FM25041
Discontinued productMelagatran
CAS:Controlled ProductStability Hygroscopic Applications Synthetic thrombin inhibitor. Thrombin mutant anticoagulant antagonist. Antithrombotic. References Dewanjee, M., et al.: J. Nucl. Med., 22, 981 (1981), Goodman, S., et al.: J. Biomed. Mater. Res., 45, 240 (1999), Carlsson, S., et al.: Thromb. Res., 115, 9 (2005),Formula:C22H31N5O4Color and Shape:NeatMolecular weight:429.51Melagatran-d11
CAS:Controlled ProductFormula:C22D11H20N5O4Color and Shape:NeatMolecular weight:440.58Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]-
CAS:Formula:C22H31N5O4Purity:98%Color and Shape:SolidMolecular weight:429.5126Melagatran
CAS:Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin.Cost-effective and quality-assured.Formula:C22H31N5O4Purity:100% - 98.37%Color and Shape:SolidMolecular weight:429.51Ref: TM-T11994
1mg513.00€5mg1,198.00€10mg1,549.00€25mg2,337.00€50mg3,125.00€100mg4,246.00€1mL*10mM (DMSO)1,130.00€
![Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-c…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA001RE6.jpg&w=3840&q=75)
